Therapeutic Effects of ALT-803, an IL-15 Superagonist, in Combination with Anti-CD20 Chimeric Antigen Receptor Modified Expanded Natural Killer Cells Against Burkitt Lymphoma (BL)

Citation data:

Cytotherapy, ISSN: 1465-3249, Vol: 18, Issue: 6, Page: S96

Publication Year:
2016

No metrics available.

DOI:
10.1016/j.jcyt.2016.03.194
Author(s):
Y. Chu; F. Lee; J. Ayello; B. Hang; M. Zhang; H. Wong; D. Lee; M. Cairo
Publisher(s):
Elsevier BV